Revibe Technologies Promotes Chief Technical Officer, Welcomes Chief Scientific Officer and Financial Controller as Company Develops ADHD Digital Therapeutic
New CSO brings substantial experience in psychological test development, Controller in accounting and auditing for the healthcare industry
News provided by
Share this article
WAKE FOREST, N.C., April 28, 2021 /PRNewswire/
Revibe Technologies today announced the hiring of Dr. Lindsay Ayearst as Chief Scientific Officer, a new position created to facilitate the clinical and regulatory development of the company s upcoming state-of-the-art digital wearable therapeutic device. In addition, Jen Musso, CPA joins the team as Financial Controller. Chris Guidry who has served as Revibe s Director of Technology since 2017 was also promoted to Chief Technical Officer. This restructuring will be crucial to the company as it works towards developing a next-generation Revibe platform as a medical device to assess and treat ADHD.
WAKE FOREST Revibe Technologies will invest in the clinical and regulatory development of its flagship product, Revibe Connect, a digital therapeutic smartwatch device powered by artificial intelligence after closing $3 million in funding led by the Carolina Angel Network. To lead this effort, company founder Rich Brancaccio will transition from the role of CEO to the role of chief innovation officer, and the company will hire Joseph Koziak as its new CEO, it announced in a statement.
The company’s product aims to assist children with autism and attention deficit hyperactivity disorder (ADHD) with maintaining focus, using an algorithm backed by artificial intelligence that sends vibration signals to a user wearing the device.